TY  - GEN

T1  - Pulmonary Hypertension: Intensification and Personalisation of Combination Rx (PHoenix): A phase IV randomised trial for the evaluation of dose-response and clinical efficacy of riociguat and selexipag using implanted technologies

T2  - Cold Spring Harbor Laboratory

UR  - http://dx.doi.org/10.1101/2023.08.24.23294547

PY  - 2023/08/24

AU  - Varian F

AU  - Dick J

AU  - Battersby C

AU  - Roman S

AU  - Ablott J

AU  - Watson L

AU  - Binmahfooz S

AU  - Zafar H

AU  - Colgan G

AU  - Cannon J

AU  - Suntharalingam J et al

ED  - 

DO  - DOI: 10.1101/2023.08.24.23294547

Y2  - 2024/12/22

ER  -